Ephrine Plus Tablet — Class II food recall F-0721-2022
Terminated recall by ULTRAtab Laboratories, Inc., reported 2022-02-16, distributed in FL, NY. cGMP Deviations
| Recall number | F-0721-2022 |
|---|---|
| Product type | Food |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ULTRAtab Laboratories, Inc., Highland, NY, United States |
| Recall initiated | 2021-10-06 |
| Classified | 2022-02-09 |
| Reported by FDA | 2022-02-16 |
| Terminated | 2022-09-01 |
| Distributed | FL, NY |
| Quantity | 4,250,842 tablets |
| Reason classes | cgmp |
| Lot numbers | 16K038, 18B075 |
Product
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-0721-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.